Murphy Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.05M | Buy |
11,053
+1,138
| +11% | +$118K | 0.15% | 107 |
|
|
2022
Q1 | $1.17M | Buy |
9,915
+697
| +8% | +$78.2K | 0.14% | 106 |
|
|
2021
Q4 | $1.19M | Sell |
9,218
-284
| -3% | -$33.1K | 0.13% | 111 |
|
|
2021
Q3 | $1.07M | Buy |
9,502
+227
| +2% | +$25.9K | 0.13% | 110 |
|
|
2021
Q2 | $960K | Buy |
9,275
+45
| +0.5% | +$4.24K | 0.11% | 115 |
|
|
2021
Q1 | $771K | Buy |
9,230
+175
| +2% | +$14.8K | 0.1% | 128 |
|
|
2020
Q4 | $826K | Buy |
9,055
+95
| +1% | +$7.88K | 0.11% | 119 |
|
|
2020
Q3 | $715K | Buy |
8,960
+90
| +1% | +$7.02K | 0.1% | 120 |
|
|
2020
Q2 | $613K | Buy |
8,870
+65
| +0.7% | +$4.62K | 0.1% | 126 |
|
|
2020
Q1 | $553K | Hold |
8,805
| – | – | 0.1% | 128 |
|
|
2019
Q4 | $684K | Sell |
8,805
-900
| -9% | -$70.3K | 0.1% | 137 |
|
|
2019
Q3 | $711K | Sell |
9,705
-300
| -3% | -$21.1K | 0.11% | 134 |
|
|
2019
Q2 | $616K | Sell |
10,005
-600
| -6% | -$36.3K | 0.09% | 145 |
|
|
2019
Q1 | $676K | Sell |
10,605
-507
| -5% | -$28.9K | 0.1% | 142 |
|
|
2018
Q4 | $567K | Hold |
11,112
| – | – | 0.1% | 152 |
|
|
2018
Q3 | $644K | Sell |
11,112
-900
| -7% | -$44K | 0.09% | 160 |
|
|
2018
Q2 | $582K | Hold |
12,012
| – | – | 0.08% | 165 |
|
|
2018
Q1 | $558K | Hold |
12,012
| – | – | 0.08% | 164 |
|
|
2017
Q4 | $451K | Sell |
12,012
-75
| -0.6% | -$2.75K | 0.06% | 186 |
|
|
2017
Q3 | $440K | Sell |
12,087
-825
| -6% | -$31.5K | 0.06% | 188 |
|
|
2017
Q2 | $508K | Sell |
12,912
-900
| -7% | -$32.9K | 0.07% | 175 |
|
|
2017
Q1 | $433K | Hold |
13,812
| – | – | 0.06% | 198 |
|
|
2016
Q4 | $431K | Sell |
13,812
-1,200
| -8% | -$38.9K | 0.07% | 193 |
|
|
2016
Q3 | $603K | Sell |
15,012
-600
| -4% | -$22.6K | 0.09% | 177 |
|
|
2016
Q2 | $518K | Buy |
15,612
+2,700
| +21% | +$92.4K | 0.08% | 193 |
|
|
2016
Q1 | $379K | Sell |
12,912
-900
| -7% | -$24.8K | 0.06% | 212 |
|
|
2015
Q4 | $363K | Hold |
13,812
| – | – | 0.06% | 222 |
|
|
2015
Q3 | $327K | Hold |
13,812
| – | – | 0.05% | 230 |
|
|
2015
Q2 | $327K | Hold |
13,812
| – | – | 0.05% | 247 |
|
|
2015
Q1 | $327K | Sell |
13,812
-6,000
| -30% | -$135K | 0.05% | 254 |
|
|
2014
Q4 | $420K | Sell |
19,812
-1,800
| -8% | -$36.2K | 0.06% | 220 |
|
|
2014
Q3 | $367K | Hold |
21,612
| – | – | 0.06% | 243 |
|
|
2014
Q2 | $309K | Hold |
21,612
| – | – | 0.05% | 261 |
|
|
2014
Q1 | $267K | Hold |
21,612
| – | – | 0.04% | 284 |
|
|
2013
Q4 | $236K | Hold |
21,612
| – | – | 0.04% | 282 |
|
|
2013
Q3 | $250K | Hold |
21,612
| – | – | 0.05% | 268 |
|
|
2013
Q2 | $242K | Buy |
+21,612
| New | +$256K | 0.05% | 254 |
|
Other funds holding EW
Murphy Capital Management's EW Position: Q2 2022 in Review
Murphy Capital Management increased its Edwards Lifesciences (EW) stake by 11% in Q2 2022, buying an estimated $118K and bringing the position to 11,053 shares worth $1.05M. The position accounts for 0.15% of the portfolio, ranked #107.
Murphy Capital Management first reported a position in EW in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.19M in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.
- Murphy Capital Management held 11,053 shares of Edwards Lifesciences worth $1.05M as of Q2 2022.
- Murphy Capital Management bought 1,138 Edwards Lifesciences shares in Q2 2022, an estimated $118K.
- Edwards Lifesciences made up 0.15% of Murphy Capital Management's portfolio in Q2 2022, its #107 holding.
- Murphy Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 37 quarters since.
- Murphy Capital Management's Edwards Lifesciences position peaked at $1.19M in Q4 2021.
- 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.
Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.